Verrica PharmaceuticalsVRCA
那斯達克 · USD
6.06
+0.16
(+2.71%)
收盤 05/23 03:59 (UTC+8)
05/23 03:59 (UTC+8)
Verrica PharmaceuticalsVRCA
6.06
+0.16
(+2.71%)
財務數據
損益表
- 0.02
- 0.04
- 0.05
- -0.02
- 0.00
- 0.03
- 0.13
- 0.14
- 0.05
- 0.05
- -31.85
- 92.45
- 35.31
- -
- -
- 899.71
- 269.35
- 12.93
- -64.50
- -1.36
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 5,023 | 5,092 | 14,344 | 12,702 | 3,439 | 344 | -1,781 | 5,177 | 3,826 | 1,988 |
營業成本 | 889 | 1,401 | 1,109 | 494 | 437 | 625 | 435 | 542 | 1,138 | 272 |
營業毛利 | 4,134 | 3,691 | 13,235 | 12,208 | 3,002 | -281 | -2,216 | 4,635 | 2,688 | 1,716 |
營業費用 | 13,849 | 10,637 | 11,608 | 10,698 | 11,132 | 11,046 | 18,488 | 19,841 | - | 22,315 |
研發費用 | 3,860 | 2,520 | 2,205 | 1,846 | 2,284 | 1,168 | 2,405 | 3,319 | 4,948 | 5,320 |
推銷及管理費用 | 9,989 | 8,117 | 9,403 | 8,852 | 8,848 | 9,878 | 16,083 | 16,522 | 16,339 | 16,995 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -9,715 | -7,192 | 1,627 | 1,510 | -8,130 | -11,410 | -20,704 | -15,206 | -18,599 | -23,136 |
其他收入及費用 | 193 | 186 | 193 | 825 | 591 | -2,526 | - | 388 | 587 | -1,710 |
利息費用 | 160 | 1,314 | 2,094 | 2,131 | 2,203 | 2,349 | 2,376 | 2,368 | 2,319 | 2,305 |
稅前純益 | -9,682 | -8,074 | -274 | 204 | -9,742 | -16,202 | -22,860 | -17,186 | -20,331 | -24,614 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -9,682 | -8,074 | -274 | 204 | -9,742 | -16,202 | -22,860 | -17,186 | -20,331 | -24,614 |
基本每股稅後盈餘(元) | -0.45 | -0.57 | -0.03 | 0.00 | -0.10 | -0.24 | -0.49 | -0.37 | -0.44 | - |
稀釋每股稅後盈餘(元) | -0.45 | -0.65 | -0.02 | 0.00 | -0.10 | -0.18 | -0.49 | -0.37 | -0.44 | -0.54 |
基本平均股數(千股) | 21305.00 | 14109.00 | 9490.00 | 94880.00 | 94837.00 | 67325.00 | 46805.00 | 46502.00 | 46483.00 | - |
稀釋平均股數(千股) | 21305.00 | 14109.00 | 9490.00 | 94906.00 | 94837.00 | 67325.00 | 46805.00 | 46502.00 | 46483.00 | - |
還原基本每股稅後盈餘(元) | -0.45 | -0.57 | -0.03 | 0.02 | -1.03 | -2.40 | -4.90 | -3.70 | -0.44 | - |
還原稀釋每股稅後盈餘(元) | -0.45 | -0.65 | -0.02 | 0.02 | -1.03 | -1.82 | -4.90 | -3.70 | -0.44 | -0.54 |
還原基本平均股數(千股) | 21,305 | 14,109 | 9,490 | 9,488 | 9,483 | 6,732 | 4,680 | 4,650 | 46,483 | - |
還原稀釋平均股數(千股) | 21,305 | 14,109 | 9,490 | 9,490 | 9,483 | 6,732 | 4,680 | 4,650 | 46,483 | - |
EBITDA(千元) | -9,328 | -6,894 | 2,379 | 2,534 | -7,331 | -13,600 | -20,142 | -14,484 | -17,672 | -22,092 |